{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:14:40Z","timestamp":1790540080627,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41431-019-0366-9","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T15:04:39Z","timestamp":1550502279000},"page":"1081-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment"],"prefix":"10.1038","volume":"27","author":[{"given":"Volkan","family":"Okur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan T.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"van Oirschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Picker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Coury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Manwaring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen Clark","family":"Muraresku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8397-4078","authenticated-orcid":false,"given":"Peter J.","family":"Hulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holley","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Place","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Bujakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Telegrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganka","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin G.","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Begtrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame","family":"Anyane-Yeboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"366_CR1","doi-asserted-by":"publisher","first-page":"265ra168","DOI":"10.1126\/scitranslmed.3010076","volume":"6","author":"SE Soden","year":"2014","unstructured":"Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014;6:265ra168.","journal-title":"Sci Transl Med"},{"key":"366_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/mp.2012.58","volume":"18","author":"CS Ku","year":"2013","unstructured":"Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, et al. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry. 2013;18:141\u201353.","journal-title":"Mol Psychiatry"},{"key":"366_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1182\/blood-2002-05-1599","volume":"100","author":"H Kanno","year":"2002","unstructured":"Kanno H, Murakami K, Hariyama Y, Ishikawa K, Miwa S, Fujii H. Homozygous intragenic deletion of type I hexokinase gene causes lethal hemolytic anemia of the affected fetus. Blood. 2002;100:1930.","journal-title":"Blood"},{"key":"366_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/blood-2002-06-1851","volume":"101","author":"R van Wijk","year":"2003","unstructured":"van Wijk R, Rijksen G, Huizinga EG, Nieuwenhuis HK, van Solinge WW. HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia. Blood. 2003;101:345\u20137.","journal-title":"Blood"},{"key":"366_CR5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/ejhg.2009.99","volume":"17","author":"J Hantke","year":"2009","unstructured":"Hantke J, Chandler D, King R, Wanders RJ, Angelicheva D, Tournev I, et al. A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy\u2014Russe (HMSNR). Eur J Hum Genet. 2009;17:1606\u201314.","journal-title":"Eur J Hum Genet"},{"key":"366_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/cge.12015","volume":"83","author":"T Sevilla","year":"2013","unstructured":"Sevilla T, Martinez-Rubio D, Marquez C,\u00a0Paradas C, Colomer J, Jaijo T, et al. Genetics of the Charcot-Marie-Tooth disease in the Spanish Gypsy population: the hereditary motor and sensory neuropathy-Russe in depth. Clin Genet. 2013;83:565\u201370.","journal-title":"Clin Genet"},{"key":"366_CR7","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1167\/iovs.14-15419","volume":"55","author":"LS Sullivan","year":"2014","unstructured":"Sullivan LS, Koboldt DC, Bowne SJ,\u00a0Lang S, Blanton SH, Cadena E, et al. A dominant mutation in hexokinase 1 (HK1) causes retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55:7147\u201358.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"366_CR8","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1167\/iovs.14-15520","volume":"55","author":"F Wang","year":"2014","unstructured":"Wang F, Wang Y, Zhang B,\u00a0Zhao L, Lyubasyuk V, Wang K, et al. A missense mutation in HK1 leads to autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55:7159\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"366_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07629-3","volume":"7","author":"Z Yuan","year":"2017","unstructured":"Yuan Z, Li B, Xu M, Chang EY, Li H, Yang L, et al. The phenotypic variability of HK1-associated retinal dystrophy. Sci Rep. 2017;7:7051.","journal-title":"Sci Rep"},{"key":"366_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2015.07.014","volume":"97","author":"AJ Tanaka","year":"2015","unstructured":"Tanaka AJ, Cho MT, Millan F, Juusola J, Retterer K, Joshi C, et al. Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss. Am J Hum Genet. 2015;97:457\u201364.","journal-title":"Am J Hum Genet"},{"key":"366_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0341-9","volume":"8","author":"H Hu","year":"2016","unstructured":"Hu H, Coon H, Li M, Yandell M, Huff CD. VARPRISM: incorporating variant prioritization in tests of de novo mutation association. Genome Med. 2016;8:91.","journal-title":"Genome Med"},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56\u201365.","journal-title":"Nature"},{"key":"366_CR13","doi-asserted-by":"crossref","unstructured":"Samocha KE, Kosmicki JA, Karczewski KJ, O'Donnell-Luria AH, Pierce-Hoffman E, MacArthur DG, et al. Regional missense constraint improves variant deleteriousness prediction. bioRxiv. 2017;148353.","DOI":"10.1101\/148353"},{"key":"366_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcmd.2016.04.002","volume":"59","author":"P Koralkova","year":"2016","unstructured":"Koralkova P, Mojzikova R, van Oirschot B, Macartney C, Timr P, Vives Corrons JL, et al. Molecular characterization of six new cases of red blood cell hexokinase deficiency yields four novel mutations in HK1. Blood Cells Mol Dis. 2016;59:71\u20136.","journal-title":"Blood Cells Mol Dis"},{"key":"366_CR15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V75.3.770.770","volume":"75","author":"K Murakami","year":"1990","unstructured":"Murakami K, Blei F, Tilton W, Seaman C, Piomelli S. An isozyme of hexokinase specific for the human red blood cell (HKR). Blood. 1990;75:770\u20135.","journal-title":"Blood"},{"key":"366_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1098-2795(199605)44:1<14::AID-MRD2>3.0.CO;2-W","volume":"44","author":"C Mori","year":"1996","unstructured":"Mori C, Nakamura N, Welch JE, Shiota K, Eddy EM. Testis-specific expression of mRNAs for a unique human type 1 hexokinase lacking the porin-binding domain. Mol Reprod Dev. 1996;44:14\u201322.","journal-title":"Mol Reprod Dev"},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1095\/biolreprod49.2.191","volume":"49","author":"C Mori","year":"1993","unstructured":"Mori C, Welch JE, Fulcher KD, O\u2019Brien DA, Eddy EM. Unique hexokinase messenger ribonucleic acids lacking the porin-binding domain are developmentally expressed in mouse spermatogenic cells. Biol Reprod. 1993;49:191\u2013203.","journal-title":"Biol Reprod"},{"key":"366_CR18","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1128\/MCB.23.20.7315-7328.2003","volume":"23","author":"JC Rathmell","year":"2003","unstructured":"Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol. 2003;23:7315\u201328.","journal-title":"Mol Cell Biol"},{"key":"366_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/bj20031465","volume":"377","author":"H Azoulay-Zohar","year":"2004","unstructured":"Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J. 2004;377:347\u201355.","journal-title":"Biochem J"},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","volume":"16","author":"N Majewski","year":"2004","unstructured":"Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell. 2004;16:819\u201330.","journal-title":"Mol Cell"},{"key":"366_CR21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1101\/gad.889901","volume":"15","author":"K Gottlob","year":"2001","unstructured":"Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt\/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15:1406\u201318.","journal-title":"Genes Dev"},{"key":"366_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1128\/MCB.24.2.730-740.2004","volume":"24","author":"N Majewski","year":"2004","unstructured":"Majewski N, Nogueira V, Robey RB, Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol. 2004;24:730\u201340.","journal-title":"Mol Cell Biol"},{"key":"366_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3324\/haematol.2008.002881","volume":"94","author":"KM de Vooght","year":"2009","unstructured":"de Vooght KM, van Solinge WW, van Wesel AC, Kersting S, van Wijk R. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis. Haematologica. 2009;94:1203\u201310.","journal-title":"Haematologica"},{"key":"366_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1006\/bcmd.1995.0002","volume":"21","author":"M Bianchi","year":"1995","unstructured":"Bianchi M, Magnani M. Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995;21:2\u20138.","journal-title":"Blood Cells Mol Dis"},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14217","volume":"143","author":"MF Dohrn","year":"2017","unstructured":"Dohrn MF, Glockle N, Mulahasanovic L, Heller C, Mohr J, Bauer C, et al. Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies. J Neurochem. 2017;143:507\u201322.","journal-title":"J Neurochem"},{"key":"366_CR26","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2337\/db12-1414","volume":"62","author":"JC Henquin","year":"2013","unstructured":"Henquin JC, Sempoux C, Marchandise J, Godecharles S, Guiot Y, Nenquin M, et al. Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of beta-cells. Diabetes. 2013;62:1689\u201396.","journal-title":"Diabetes"},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000351943","volume":"80","author":"SE Pinney","year":"2013","unstructured":"Pinney SE, Ganapathy K, Bradfield J,\u00a0Stokes D, Sasson A, Mackiewicz K, et al. Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. Horm Res Paediatr. 2013;80:18\u201327.","journal-title":"Horm Res Paediatr"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"19548","DOI":"10.1074\/jbc.273.31.19548","volume":"273","author":"TY Fang","year":"1998","unstructured":"Fang TY, Alechina O, Aleshin AE, Fromm HJ, Honzatko RB. Identification of a phosphate regulatory site and a low affinity binding site for glucose 6-phosphate in the N-terminal half of human brain hexokinase. J Biol Chem. 1998;273:19548\u201353.","journal-title":"J Biol Chem"},{"key":"366_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0003-9861(02)00029-2","volume":"401","author":"D Sui","year":"2002","unstructured":"Sui D, Wilson JE. Functional interactions between the noncovalently associated N- and C-terminal halves of mammalian Type I hexokinase. Arch Biochem Biophys. 2002;401:21\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"366_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/abbi.2001.2744","volume":"399","author":"M Hashimoto","year":"2002","unstructured":"Hashimoto M, Wilson JE. Kinetic and regulatory properties of HK I(+), a modified form of the type I isozyme of mammalian hexokinase in which interactions between the N- and C-terminal halves have been disrupted. Arch Biochem Biophys. 2002;399:109\u201315.","journal-title":"Arch Biochem Biophys"},{"key":"366_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF01496345","volume":"50","author":"KM Goebel","year":"1972","unstructured":"Goebel KM, Gassel WD, Goebel FD, Kaffarnik H. Hemolytic anemia and hexokinase deficiency associated with malformations. Klin Wochenschr. 1972;50:849\u201351.","journal-title":"Klin Wochenschr"},{"key":"366_CR32","first-page":"636","volume":"132","author":"F Gilsanz","year":"1978","unstructured":"Gilsanz F, Meyer E, Paglia DE, Valentine WN. Congenital hemolytic anemia due to hexokinase deficiency. Am J Dis Child. 1978;132:636\u20137.","journal-title":"Am J Dis Child"},{"key":"366_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2141.1985.tb04058.x","volume":"61","author":"M Magnani","year":"1985","unstructured":"Magnani M, Stocchi V, Canestrari F, Dacha M, Balestri P, Farnetani MA, et al. Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties. Br J Haematol. 1985;61:41\u201350.","journal-title":"Br J Haematol"},{"key":"366_CR34","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1073\/pnas.0813178106","volume":"106","author":"R Datta","year":"2009","unstructured":"Datta R, Waheed A, Bonapace G, Shah GN, Sly WS. Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. Proc Natl Acad Sci Usa. 2009;106:3437\u201342.","journal-title":"Proc Natl Acad Sci Usa"},{"key":"366_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.1146361","volume":"318","author":"JH Lin","year":"2007","unstructured":"Lin JH, Li H, Yasumura D,\u00a0Cohen HR, Zhang C, Panning B, et al. IRE1 signaling affects cell fate during the unfolded protein response. Science. 2007;318:944\u20139.","journal-title":"Science"},{"key":"366_CR36","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/jcmm.13149","volume":"21","author":"MS Kane","year":"2017","unstructured":"Kane MS, Alban J, Desquiret-Dumas V, Gueguen N, Ishak L, Ferre M, et al. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy. J Cell Mol Med. 2017;21:2284\u201397.","journal-title":"J Cell Mol Med"},{"key":"366_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133:771\u201386.","journal-title":"Brain"},{"key":"366_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bioinformatics\/btr621","volume":"28","author":"E Becker","year":"2012","unstructured":"Becker E, Robisson B, Chapple CE, Guenoche A, Brun C. Multifunctional proteins revealed by overlapping clustering in protein interaction network. Bioinformatics. 2012;28:84\u201390.","journal-title":"Bioinformatics"},{"key":"366_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8412","volume":"6","author":"CE Chapple","year":"2015","unstructured":"Chapple CE, Robisson B, Spinelli L, Guien C, Becker E, Brun C. Extreme multifunctional proteins identified from a human protein interaction network. Nat Commun. 2015;6:7412.","journal-title":"Nat Commun"},{"key":"366_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1677\/joe.0.1470383","volume":"147","author":"RM Campbell","year":"1995","unstructured":"Campbell RM, Scanes CG. Endocrine peptides \u2018moonlighting\u2019 as immune modulators: roles for somatostatin and GH-releasing factor. J Endocrinol. 1995;147:383\u201396.","journal-title":"J Endocrinol"},{"key":"366_CR41","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1086\/430799","volume":"76","author":"G Sriram","year":"2005","unstructured":"Sriram G, Martinez JA, McCabe ER, Liao JC, Dipple KM. Single-gene disorders: what role could moonlighting enzymes play? Am J Hum Genet. 2005;76:911\u201324.","journal-title":"Am J Hum Genet"},{"key":"366_CR42","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1038\/sj.onc.1209595","volume":"25","author":"RB Robey","year":"2006","unstructured":"Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006;25:4683\u201396.","journal-title":"Oncogene"},{"key":"366_CR43","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cellsig.2010.04.010","volume":"22","author":"A Schindler","year":"2010","unstructured":"Schindler A, Foley E. A functional RNAi screen identifies hexokinase 1 as a modifier of type II apoptosis. Cell Signal. 2010;22:1330\u201340.","journal-title":"Cell Signal"},{"key":"366_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bbrc.2013.03.016","volume":"433","author":"TA Craig","year":"2013","unstructured":"Craig TA, Ramachandran PL, Bergen HR 3rd, Podratz JL, Windebank AJ, Kumar R. The regulation of apoptosis by the downstream regulatory element antagonist modulator\/potassium channel interacting protein 3 (DREAM\/KChIP3) through interactions with hexokinase I. Biochem Biophys Res Commun. 2013;433:508\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"366_CR45","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.cellsig.2013.08.035","volume":"25","author":"A Schindler","year":"2013","unstructured":"Schindler A, Foley E. Hexokinase 1 blocks apoptotic signals at the mitochondria. Cell Signal. 2013;25:2685\u201392.","journal-title":"Cell Signal"},{"key":"366_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychires.2011.09.018","volume":"46","author":"WT Regenold","year":"2012","unstructured":"Regenold WT, Pratt M, Nekkalapu S, Shapiro PS, Kristian T, Fiskum G. Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling. J Psychiatr Res. 2012;46:95\u2013104.","journal-title":"J Psychiatr Res"},{"key":"366_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2014.01.028","volume":"154","author":"D Shan","year":"2014","unstructured":"Shan D, Mount D, Moore S, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia. Schizophr Res. 2014;154:1\u201313.","journal-title":"Schizophr Res"},{"key":"366_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/hmg\/ddt407","volume":"23","author":"MK McCoy","year":"2014","unstructured":"McCoy MK, Kaganovich A, Rudenko IN, Ding J, Cookson MR. Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. Hum Mol Genet. 2014;23:145\u201356.","journal-title":"Hum Mol Genet"},{"key":"366_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2012.10.041","volume":"428","author":"K Okatsu","year":"2012","unstructured":"Okatsu K, Iemura S, Koyano F, Go E, Kimura M, Natsume T, et al. Mitochondrial hexokinase HKI is a novel substrate of the Parkin ubiquitin ligase. Biochem Biophys Res Commun. 2012;428:197\u2013202.","journal-title":"Biochem Biophys Res Commun"},{"key":"366_CR50","doi-asserted-by":"publisher","first-page":"e15230","DOI":"10.1371\/journal.pone.0015230","volume":"5","author":"LM Saraiva","year":"2010","unstructured":"Saraiva LM, Seixas da Silva GS, Galina A, da-Silva WS, Klein WL, Ferreira ST, et al. Amyloid-beta triggers the release of neuronal hexokinase 1 from mitochondria. PLoS ONE. 2010;5:e15230.","journal-title":"PLoS One"},{"key":"366_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature21062","volume":"542","author":"Deciphering Developmental Disorders Study.","year":"2017","unstructured":"Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433\u20138.","journal-title":"Nature"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0366-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0366-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:59:28Z","timestamp":1684616368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-019-0366-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1038\/s41431-019-0366-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Megan Cho, Aida Telegrafi, Ganka Douglas, Kristin G. Monaghan, Amber Begtrup, and Kyle Retterer are employees of GeneDx.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}